Is it Time to Dump TRACON Pharmaceuticals Inc (TCON) Stock After it Has Risen 18.62% in a Week?

Tuesday, August 16, 2022 02:30 PM | InvestorsObserver Analysts

Mentioned in this article

TRACON Pharmaceuticals Inc (TCON) stock is higher by 18.62% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

TRACON Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TCON!
See Full TCON Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With TCON Stock Today?

TRACON Pharmaceuticals Inc (TCON) stock is trading at $2.23 as of 2:28 PM on Tuesday, Aug 16, a rise of $0.11, or 5.19% from the previous closing price of $2.12. The stock has traded between $2.12 and $2.32 so far today. Volume today is more active than usual. So far 120,110 shares have traded compared to average volume of 52,323 shares. To see InvestorsObserver's Sentiment Score for TRACON Pharmaceuticals Inc click here.

More About TRACON Pharmaceuticals Inc

TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, TJ4309, Bispecific Antibodies. Click Here to get the full Stock Report for TRACON Pharmaceuticals Inc stock.

Share this article:

Related Articles